文献速递肿瘤 PET/CT放射性药物与辐射防护

结核病小鼠模型中CSF1R的PET/CT成像

PET/CT imaging of CSF1R in a mouse model of tuberculosis.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2022-06-17

本研究以[11C]JNJ-28312141为CSF1R选择性拮抗剂放射性示踪剂,在慢性肺结核C3HeB/FeJ小鼠模型中进行PET/CT成像,并与CT所见解剖病灶共定位;感染小鼠肺部病灶摄取为5.58-12.49% ID/g,感染病灶肺/健康肺摄取比为5.91:1,病灶/邻近感染透亮肺摄取比为2.8:1,预给未标记JNJ-28312141可明显阻断摄取,免疫荧光显示CSF1R与Iba1+巨噬细胞共定位。

要点

  • [11C]JNJ-28312141放射合成平均非衰变校正产率为18.7±2.1%,放射化学纯度99%,比活度平均658±141 GBq/µmol。
  • 感染小鼠出现局灶性肺部病灶摄取(5.58-12.49% ID/g),感染病灶肺/健康肺摄取比为5.91:1,病灶/邻近感染透亮肺摄取比为2.8:1。
  • 预给1 mg/kg未标记JNJ-28312141后感染动物出现明显阻断,荧光显微镜显示CSF1R染色与丰富Iba1+巨噬细胞共定位。

核心结论

  • [11C]JNJ-28312141特异性结合CSF1R+巨噬细胞,并在小鼠肺结核模型中勾画肉芽肿性病灶。

研究设计与样本

  • 研究在慢性肺结核C3HeB/FeJ小鼠模型中进行PET/CT成像,以共定位放射性示踪剂摄取与CT所见的肉芽肿性病灶。
  • 对感染与健康小鼠进行CSF1R、Iba1荧光免疫组化,以共定位CSF1R靶点与反应性巨噬细胞。

主要发现

  • [11C]JNJ-28312141放射合成平均非衰变校正产率为18.7±2.1%,放射化学纯度99%,比活度平均658±141 GBq/µmol(合成结束时)。
  • 健康小鼠注射后40-50分钟PET/CT显示肝胆摄取为13.39-25.34% ID/g,肾脏摄取为12.35% ID/g。
  • 感染小鼠显示局灶性肺部病灶摄取5.58-12.49% ID/g、肝胆摄取15.30-40.50% ID/g、颈部淋巴结摄取及肾脏摄取11.66-29.33% ID/g。
  • 感染病灶肺/健康肺摄取比为5.91:1,病灶摄取/邻近感染透亮肺摄取比为2.8:1。
  • 感染动物预给1 mg/kg未标记JNJ-28312141后[11C]JNJ-28312141摄取出现明显阻断;荧光显微镜显示感染与未感染全肺切片中CSF1R染色仅与丰富Iba1+巨噬细胞共定位,健康肺无CSF1R染色且Iba1+巨噬细胞极少。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Macrophages represent an essential means of sequestration and immune evasion for Mycobacterium tuberculosis. Pulmonary tuberculosis (TB) is characterized by dense collections of tissue-specific and recruited macrophages, both of which abundantly express CSF1R on their outer surface. 4-Cyano-N-(5-(1-(dimethylglycyl)piperidin-4-yl)-2',3',4',5'-tetrahydro-[1,1'-biphenyl]-2-yl)-1H-imidazole-2-carboxamide (JNJ-28312141) is a reported high affinity, CSF1R-selective antagonist. We report the radiosynthesis of 4-cyano-N-(5-(1-(N-methyl-N-([11C]methyl)glycyl)piperidin-4-yl)-2',3',4',5'-tetrahydro-[1,1'-biphenyl]-2-yl)-1H-imidazole-2-carboxamide ([11C]JNJ-28312141) and non-invasive detection of granulomatous and diffuse lesions in a mouse model of TB using positron emission tomography (PET). METHODS: Nor-methyl-JNJ-28312141 precursor was radiolabeled with [11C]iodomethane to produce [11C]JNJ-28312141. PET/CT imaging was performed in the C3HeB/FeJ murine model of chronic pulmonary TB to co-localize radiotracer uptake with granulomatous lesions observed on CT. Additionally, CSF1R, Iba1 fluorescence immunohistochemistry was performed to co-localize CSF1R target with reactive macrophages in infected and healthy mice. RESULTS: Radiosynthesis of [11C]JNJ-28312141 averaged a non-decay-corrected yield of 18.7 ± 2.1%, radiochemical purity of 99%, and specific activity averaging 658 ± 141 GBq/µmol at the end-of-synthesis. PET/CT imaging in healthy mice showed hepatobiliary [13.39-25.34% ID/g, percentage of injected dose per gram of tissue (ID/g)] and kidney uptake (12.35% ID/g) at 40-50 min post-injection. Infected mice showed focal pulmonary lesion uptake (5.58-12.49% ID/g), hepatobiliary uptake (15.30-40.50% ID/g), cervical node uptake, and renal uptake (11.66-29.33% ID/g). The ratio of infected lesioned lung/healthy lung uptake is 5.91:1, while the ratio of lesion uptake to adjacent infected radiolucent lung is 2.8:1. Pre-administration of 1 mg/kg of unlabeled JNJ-28312141 with [11C]JNJ-28312141 in infected animals resulted in substantial blockade. Fluorescence microscopy of infected and uninfected whole lung sections exclusively co-localized CSF1R staining with abundant Iba1 + macrophages. Healthy lung exhibited no CSF1R staining and very few Iba1 + macrophages. CONCLUSION: [11C]JNJ-28312141 binds specifically to CSF1R + macrophages and delineates granulomatous foci of disease in a murine model of pulmonary TB.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Foss CA, Ordonez AA, Naik R, et al. PET/CT imaging of CSF1R in a mouse model of tuberculosis. Eur J Nucl Med Mol Imaging. 2022. PMID: 35713665. doi:10.1007/s00259-022-05862-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。